Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Liminal BioSciences Inc. LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed... see more

NDAQ:LMNL - Post Discussion

Liminal BioSciences Inc. > Lots of headfakes today
View:
Post by Dibah420 on Mar 18, 2022 9:17am

Lots of headfakes today

But pre mkt can't get more than 8 bids!

LIMINAL BIOSCIENCES INC (US: LMNL)


          
Real-time  

Last: 0.8631   Change: 0.0000   Volume: 0   Last Trade: 03/17  

  Level ll Quote
  Bid   Ask
  Price   Total Size   # of Orders   Price   Total Size   # of Orders
$0.797 100 1 $0.90 2 1
$0.75 5 1 $0.9368 100 1
$0.67 100 1 $0.96 125 1
$0.65 400 1 $1.00 102 2
$0.62 3 1 $1.09 3 1
$0.60 1000 1 $1.10 770 1
$0.50 100 1 $1.20 20 1
$0.40 1000 1 $1.25 831 1
      $1.50 2000 1
      $1.66 428 1
Be the first to comment on this post
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities